Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ledipasvir/sofosbuvir in pediatric patients with hepatitis C undergoing cancer chemotherapy
2018-003741-42Phase 2
- Sponsor
- Gilead Sciences
- Start
- Oct 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of ledipasvir and sofosbuvir in hepatitis C virus infection, sponsored by Gilead Sciences. Primary endpoint: SVR12.
02
Drugs
ledipasvirsofosbuvir
03
Conditions
hepatitis C virus infection
Beyond the preview
Go deeper on 2018-003741-42.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2018-003741-42.